Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy

Psychological Medicine

Volumn 41, Issue 1, 2011, Pages 207-216

  Freyer, T ^a   Kloppel S ^a   Tuscher O ^a   Kordon, A ^b   Zurowski, B ^b   Kuelz, A K ^a   Speck, O ^c   Glauche, V ^a   Voderholzer, U ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d Medical Psychosomatic Hospital Roseneck   (Germany)

Author keywords

Cognitive behavioral therapy; frontostriatal dysfunction; functional brain imaging; obsessive compulsive disorder

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CAUDATE NUCLEUS; CLINICAL TRIAL; COGNITIVE THERAPY; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMAN; LEARNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PUTAMEN;

ADULT; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; COGNITIVE THERAPY; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PUTAMEN; REVERSAL LEARNING;

EID: 78650395610     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710000309     Document Type: Article

References (31)

1. Abramowitz JS (2006). The psychological treatment of obsessive-compulsive disorder. Canadian Journal of Psychiatry 51, 407-416.
2. Baxter Jr. LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE (1987). Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry 44, 211-218.
3. Baxter Jr. LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, Phelps ME (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 49, 681-689.
4. Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N, Aitken M, Craig K, Owen AM, Bullmore ET, Robbins TW, Sahakian BJ (2008). Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 321, 421-422.
5. Clarke HF, Robbins TW, Roberts AC (2008). Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. Journal of Neuroscience 28, 10972-10982.
6. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC (2007). Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cerebral Cortex 17, 18-27.
7. Cools R, Clark L, Owen AM, Robbins TW (2002). Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. Journal of Neuroscience 22, 4563-4567.
8. DeRubeis RJ, Siegle GJ, Hollon SD (2008). Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nature Reviews Neuroscience 9, 788-796.
9. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162, 151-161.
10. Frank MJ, Claus ED (2006). Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychological Review 113, 300-326.
11. Freyer T, Valerius G, Kuelz AK, Speck O, Glauche V, Hull M, Voderholzer U (2009). Test-retest reliability of event-related functional MRI in a probabilistic reversal learning task. Psychiatry Research: Neuroimaging 174, 40-46.
12. Friston KJ, Frith CD, Turner R, Frackowiak RS (1995). Characterizing evoked hemodynamics with fMRI. NeuroImage 2, 157-165.
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 46, 1006-1011.
14. Gottfried JA, Smith AP, Rugg MD, Dolan RJ (2004). Remembrance of odors past: human olfactory cortex in cross-modal recognition memory. Neuron 42, 687-695.
15. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
16. Hohagen F, Winkelmann G, Rasche-Ruchle H, Hand I, Konig A, Munchau N, Hiss H, Geiger-Kabisch C, Kappler C, Schramm P, Rey E, Aldenhoff J, Berger M (1998). Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. British Journal of Psychiatry. Supplement 35, 71-78.
17. Ho Pian KL, van Megen HJ, Ramsey NF, Mandl R, van Rijk PP, Wynne HJ, Westenberg HG (2005). Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Research 138, 89-97.
18. Huey ED, Zahn R, Krueger F, Moll J, Kapogiannis D, Wassermann EM, Grafman J (2008). A psychological and neuroanatomical model of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neuroscience 20, 390-408.
19. Linden DE (2006). How psychotherapy changes the brain - the contribution of functional neuroimaging. Molecular Psychiatry 11, 528-538.
20. Maia TV, Cooney RE, Peterson BS (2008). The neural bases of obsessive-compulsive disorder in children and adults. Development and Psychopathology 20, 1251-1283.
21. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET (2008). Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews 32, 525-549.
22. Nabeyama M, Nakagawa A, Yoshiura T, Nakao T, Nakatani E, Togao O, Yoshizato C, Yoshioka K, Tomita M, Kanba S (2008). Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement. Psychiatry Research 163, 236-247.
23. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, Kudoh A, Tada K, Yoshioka K, Kawamoto M, Togao O, Kanba S (2005). Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biological Psychiatry 57, 901-910.
24. Nakatani E, Nakgawa A, Ohara Y, Goto S, Uozumi N, Iwakiri M, Yamamoto Y, Motomura K, Iikura Y, Yamagami T (2003). Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Research 124, 113-120.
25. Remijnse PL, Nielen MM, van Balkom AJ, Cath DC, van Oppen P, Uylings HB, Veltman DJ (2006). Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Archives of General Psychiatry 63, 1225-1236.
26. Remijnse PL, Nielen MM, van Balkom AJ, Hendriks GJ, Hoogendijk WJ, Uylings HB, Veltman DJ (2009). Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder. Psychological Medicine 39, 1503-1518.
27. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR (1999). Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21, 683-693.
28. Schwartz JM, Stoessel PW, Baxter Jr. LR, Martin KM, Phelps ME (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Archives of General Psychiatry 53, 109-113.
29. Valerius G, Lumpp A, Kuelz AK, Freyer T, Voderholzer U (2008). Reversal learning as a neuropsychological indicator for the neuropathology of obsessive compulsive disorder? A behavioral study. Journal of Neuropsychiatry and Clinical Neuroscience 20, 210-218.
30. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, Barkhof F, van Dyck R (2005). Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Archives of General Psychiatry 62, 301-309.
31. Whiteside SP, Port JD, Abramowitz JS (2004). A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Research 132, 69-79.